Komori
Nihon Shokuhin Kako (2892) · InitiativeRestated

Saccharification Division Capacity Expansion, Facility Renewal and Quality Improvement

First written in FY2016. 22 of 25 entries say "Advanced", first in FY2017-Q2. Latest entry: FY2026.

25entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2017-Q2 – FY20252016: 220162017: 320172018: 420182019: 320192020: 220202021: 220212022: 220222023: 220232024: 220242025: 220252026: 12026
Same theme, other companies
Expansion and Rationalization of Manufacturing FacilitiesA theme 376 companies write about · 0 as a headwind · 415 as a tailwind

10 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 182 companies compared. The sentences above are computed from all 182.Comparing 200 of the theme's 415 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026RestatedAnnual report

    「Capital expenditures for the fiscal year focused mainly on renewing existing production facilities and carrying out construction to improve product quality, bringing total capital expenditures to ¥2,716 million.」

    The company has continued renewing existing production facilities and carrying out quality-improvement work, investing ¥2,716 million during the year.
  2. FY2026-H1RestatedAnnual report

    「Cash used in investing activities amounted to ¥1,220 million. This was mainly attributable to ¥1,020 million in expenditure for the acquisition of property, plant and equipment, including investments in the company’s factory facilities, among other factors.」

    The company has continued investing in factory equipment and other assets, spending ¥1.02 billion on the acquisition of property, plant and equipment during the interim consolidated accounting period.
  3. FY2025AdvancedAnnual report

    「During the fiscal year under review, capital expenditures focused mainly on equipment related to the renewal of existing production equipment and improvement of product quality. As a result, total capital expenditures amounted to ¥5,014 million.」

    Capital expenditures increased from ¥3,958 million in the previous fiscal year to ¥5,014 million. The company continued investing in production- and quality-related facilities, including the renewal of power generation facilities at the Fuji Plant.
  4. FY2025-H1AdvancedAnnual report

    「Cash used in investing activities amounted to ¥2,200 million. This was mainly attributable to ¥1,940 million in expenditure for the acquisition of property, plant and equipment, including investments in the company’s factory facilities, among other factors.」

    The company spent ¥1,940 million during the current interim consolidated accounting period on the acquisition of property, plant and equipment, including factory facilities, and continued investment in production equipment.
  5. FY2024AdvancedAnnual report

    「During the fiscal year under review, capital expenditures focused mainly on equipment related to the renewal of existing production equipment and improvement of product quality. As a result, total capital expenditures amounted to ¥3,958 million.」

    Capital expenditures increased from ¥2,182 million in the previous fiscal year to ¥3,958 million. The company disclosed plans for the power generation facilities, raw-material corn steep liquor concentration facilities, and enzyme production facilities, including scheduled completion in March 2025, March 2027, and October 2024, respectively.
  6. FY2024-Q2AdvancedAnnual report

    「Cash used in investing activities amounted to ¥880 million. This was mainly attributable to ¥1,290 million in expenditure for the acquisition of property, plant and equipment, including investments in the company’s factory facilities, among other factors.」

    The company spent ¥1,290 million during the cumulative second quarter on the acquisition of property, plant and equipment, including factory facilities, and continued capital investment.
  7. FY2023AdvancedAnnual report

    「During the fiscal year under review, capital expenditures focused mainly on equipment related to the renewal of existing production equipment and improvement of product quality. As a result, total capital expenditures amounted to ¥2,182 million.」

    The company continued capital investment and invested ¥2,182 million during the fiscal year under review. It also continued plans to construct and renovate power generation facilities, isomerized sugar separation facilities, and enzyme production facilities.
  8. FY2023-Q2AdvancedAnnual report

    「Cash used in investing activities amounted to ¥1,520 million. This was mainly attributable to ¥1,390 million in expenditure for the acquisition of property, plant and equipment, including investments in the company’s factory facilities, among other factors.」

    The company spent ¥1,390 million during the cumulative second quarter on the acquisition of property, plant and equipment, including factory facilities, and continued capital investment.
  9. FY2022AdvancedAnnual report

    「During the fiscal year under review, capital expenditures focused mainly on equipment related to the renewal of existing production equipment and improvement of product quality. As a result, total capital expenditures amounted to ¥2,634 million.」

    The company invested ¥2,634 million during the fiscal year under review, mainly in the renewal of existing production equipment and quality improvements. It also presented plans to construct and renovate power generation facilities at the Fuji Plant at a cost of ¥3,352 million and enzyme production facilities in the fine chemicals division at a cost of ¥780 million.
  10. FY2022-Q2AdvancedAnnual report

    「Cash used in investing activities amounted to ¥1,120 million. This was mainly attributable to the net amount after deducting ¥1,610 million in expenditure for the acquisition of property, plant and equipment, including investments in the company’s factory facilities, from ¥540 million in proceeds from the collection of loans receivable, among other factors.」

    The company spent ¥1,610 million during the cumulative second quarter on the acquisition of property, plant and equipment, including factory facilities, and continued capital investment.
  11. FY2021AdvancedAnnual report

    「During the fiscal year under review, capital expenditures focused mainly on construction to renew existing production equipment and improve product quality. As a result, total capital expenditures amounted to ¥2,401 million.」

    The company invested ¥2,401 million during the fiscal year under review, mainly in the renewal of existing production equipment and quality improvement construction. It also continued the construction and renewal of starch, saccharified-product and by-product production facilities, wastewater treatment facilities, and other facilities.
  12. FY2021-Q2AdvancedAnnual report

    「Cash used in investing activities amounted to ¥950 million. This was mainly attributable to ¥860 million in expenditure for the acquisition of property, plant and equipment, including investments in the company’s factory facilities, among other factors.」

    The company spent ¥860 million during the cumulative second quarter on the acquisition of property, plant and equipment, including factory facilities, and continued capital investment.
  13. FY2020AdvancedAnnual report

    「During the fiscal year under review, capital expenditures focused mainly on construction to renew existing production equipment and construction of a new building associated with the relocation of head-office functions to the Fuji Plant. As a result, total capital expenditures amounted to ¥2,475 million.」

    In addition to renewing existing production equipment, the company carried out construction of a new building associated with the relocation of head-office functions to the Fuji Plant, and invested ¥2,475 million during the fiscal year under review.
  14. FY2020-Q2AdvancedAnnual report

    「Cash used in investing activities amounted to ¥1,770 million. This was mainly attributable to ¥1,680 million in expenditure for the acquisition of property, plant and equipment, including investments in the company’s factory facilities, among other factors.」

    The company spent ¥1,680 million during the cumulative second quarter on the acquisition of property, plant and equipment, including factory facilities, indicating progress in capital investment.
  15. FY2019AdvancedAnnual report

    「During the fiscal year under review, capital expenditures focused mainly on construction to renew existing production equipment and improve product quality. As a result, total capital expenditures amounted to ¥2,080 million.」

    The company carried out ¥2,080 million in renewal of existing production equipment and construction to improve quality. It also disclosed plans to build a new research and development and administration office at the Fuji Plant, with construction starting in November 2018, completion in March 2020, and a total cost of ¥779 million.
  16. FY2019-Q3AdvancedAnnual report

    「This was mainly attributable to the net amount after deducting ¥1,590 million in expenditure for the acquisition of property, plant and equipment, including investments in the company’s factory facilities, and ¥30 million in expenditure for the acquisition of intangible assets from ¥1,870 million in proceeds from the collection of loans receivable, among other factors.」

    The company spent ¥1,590 million during the cumulative third quarter on the acquisition of property, plant and equipment, including factory facilities.
  17. FY2019-Q2AdvancedAnnual report

    「This was mainly attributable to the net amount after deducting ¥1,190 million in expenditure for the acquisition of property, plant and equipment, including investments in the company’s factory facilities, from ¥1,870 million in proceeds from the collection of loans receivable, among other factors.」

    The company spent ¥1,190 million during the cumulative second quarter on the acquisition of property, plant and equipment, including factory facilities.
  18. FY2019-Q1AdvancedAnnual report

    「This was mainly attributable to the net amount after deducting ¥710 million in expenditure for the acquisition of property, plant and equipment, including investments in the company’s factory facilities, from ¥1,870 million in proceeds from the collection of loans receivable, among other factors.」

    The company spent ¥710 million during the cumulative first quarter on the acquisition of property, plant and equipment, including factory facilities.
  19. FY2018AdvancedAnnual report

    「During the fiscal year under review, capital expenditures focused mainly on construction to renew existing production equipment and improve product quality. As a result, total capital expenditures amounted to ¥2,070 million.」

    The company carried out ¥2,070 million in renewal of existing production equipment and construction to improve quality. It also disclosed plans to renovate the wastewater facilities at the Fuji Plant at a cost of ¥430 million from October 2018 to October 2021, and production equipment at a cost of ¥1,400 million from May 2018 to October 2023.
  20. FY2018-Q3AdvancedAnnual report

    「This was mainly attributable to the net amount after deducting ¥1,610 million in expenditure for the acquisition of property, plant and equipment, including investments in the company’s factory facilities, from ¥3,300 million in proceeds from the collection of loans receivable, among other factors.」

    The company spent ¥1,610 million during the cumulative third quarter on the acquisition of property, plant and equipment, including factory facilities.
  21. FY2018-Q2AdvancedAnnual report

    「This was mainly attributable to the net amount after deducting ¥1,340 million in expenditure for the acquisition of property, plant and equipment, including investments in the company’s factory facilities, from ¥3,150 million in proceeds from the collection of loans receivable, among other factors.」

    The company spent ¥1,340 million during the cumulative second quarter on the acquisition of property, plant and equipment, including factory facilities.
  22. FY2018-Q1AdvancedAnnual report

    「This was mainly attributable to the net amount after deducting ¥700 million in expenditure for the acquisition of property, plant and equipment, including investments in the company’s factory facilities, from ¥2,400 million in proceeds from the collection of loans receivable, among other factors.」

    The company spent ¥700 million during the cumulative first quarter on the acquisition of property, plant and equipment, including factory facilities.
  23. FY2017-Q3AdvancedAnnual report

    「This was mainly attributable to the net amount after deducting ¥1,570 million in expenditure for the acquisition of property, plant and equipment, including investments in the company’s factory facilities, and ¥1,480 million in the net increase in short-term loans receivable, among other factors.」

    Expenditure on the acquisition of property, plant and equipment, including factory facilities, totaled ¥1,570 million during the cumulative third quarter, indicating progress in capital investment.
  24. FY2017-Q2AdvancedAnnual report

    「Cash used in investing activities amounted to ¥1,570 million, up 55.1% year on year. This was mainly attributable to ¥1,300 million in expenditure for the acquisition of property, plant and equipment, including investments in the company’s factory facilities, and a net increase of ¥280 million in short-term loans receivable, among other factors.」

    The company spent ¥1,300 million during the cumulative second quarter on the acquisition of property, plant and equipment, including factory facilities.
  25. FY2016First statedAnnual report

    「During the fiscal year under review, capital expenditures focused mainly on construction to expand production capacity in the saccharification division, renewal of existing production equipment, and construction to improve product quality. As a result, total capital expenditures amounted to ¥1,850 million.」

    The company invested ¥1,850 million during the fiscal year under review in production capacity expansion, equipment renewal, and quality improvement construction.
Moved together

"Negative operating cash flow due to increases in accounts receivable and inventories" moved the same way as this thread, in the same document, in 8 of its 25 moves.

866433★123456
  1. ★This thread
  2. 1Negative operating cash flow due to increases in accounts receivable and inventories8×
  3. 2Improved profitability due to higher sales volumes and lower costs for raw materials, fuel and other items6×
  4. 3Guarantee of AMSCO’s Borrowing Obligations6×
  5. 4Outlook for lower revenue and profits in the next period4×
  6. 5Sound Corporate Management and Product Development Aligned with the SDGs3×
  7. 6Expansion of Fine Chemical Sales Driven by Increased Overseas Demand for Pharmaceutical Applications3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Nihon Shokuhin Kako's next results are scheduled for 2026-10-30. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.